Shenzhen saw its last locally transmitted COVID-19 patients discharged after recovery Tuesday evening, according to Shenzhen Third People’s Hospital, the designated hospital receiving COVID-19 patients in the city.
Three COVID-19 patients recovered and were discharged from the hospital Tuesday evening, while another patient left the hospital on an earlier date, said the hospital. The four patients had formed a local COVID-19 cluster, with the first case reported June 14.
Additionally, four confirmed COVID-19 cases and 12 asymptomatic patients of another local COVID-19 cluster that merged May 21 had all been discharged from the hospital upon recovery by July 5.
No deaths were reported in the two local COVID-19 outbreaks, according to the city’s health commission.
The patients who were discharged from the hospital Tuesday included a woman diagnosed June 21, whose epidemiological investigation went viral on the Internet after it was reported.
The 64-year-old woman, surnamed Liu, drew concerns from netizens as the epidemiological investigation showed that she had worked long hours at a restaurant in Bao’an District, with no time for morning tea or square dance.
Liu was confirmed infected with the Delta variant of COVID-19 and was admitted to Shenzhen Third People’s Hospital on June 21.
During her stay in hospital, Liu recorded a video to express her gratitude to those who cared about her, according to Shenzhen Special Zone Daily.
Few critical COVID-19 cases were reported in the two local COVID-19 outbreaks, partly due to the city government’s proactive and timely measures to screen out infected patients through mass nucleic acid testing.
Meanwhile, the extensive vaccination coverage has also played an important part in containing the spread of COVID-19.
The COVID-19 patients that had been admitted to Shenzhen Third People’s Hospital and had received COVID-19 vaccines were mostly asymptomatic or mild cases with weakened infectivity, which indicated that the domestically developed vaccines are effective in protecting against COVID-19 variants and in preventing severe or critical cases.